Phaxiam Therapeutics Aktie
| 1,59EUR | 0,00EUR | 0,00% |
WKN DE: A3EJH8 / ISIN: FR001400K4B1
Aktionärsstruktur
| Inhaber | in % |
|---|---|
| Freefloat | 98,28 |
| Royance Sélection Internationale | 2,20 |
| Armistice Capital LLC | 1,76 |
| Auriga Partners SA | 1,24 |
| Afer - Flore | 0,96 |
| GF Ambition Solidiaire | 0,70 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 217 | 206 | 181 | 49 | 68 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
Bilanz (in Mio. EUR) - Aktiva
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 82 | 50 | 40 | 43 | 16 |
| Summe Anlagevermögen | 37 | 31 | 27 | 3 | 35 |
| Summe Aktiva | 119 | 80 | 67 | 46 | 51 |
Bilanz (in Mio. EUR) - Passiva
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 33 | 54 | 44 | 22 | 26 |
| Summe Eigenkapital | 86 | 27 | 23 | 23 | 26 |
| Summe Passiva | 119 | 80 | 67 | 46 | 51 |
Adresse
| 60, avenue Rockefeller, 69008 Lyon | |
| Telefon | +33 (4) 78-74-44-38 |
| Internet | http://www.phaxiam.com |
Management
|
Anne-Cécile Fumey
Director-Human Resources |
|
Cindy Fevre
Chief Scientific Officer |
|
Céline Breda
Chief Technical Officer |
|
Didier Hoch
Chairman |
|
Eric Jean Marie Leire
Independent Director |
|
Eric Soyer
Deputy CEO, Chief Financial & Operating Officer |
|
Frédérique Vieville
Chief Regulatory Officer |
|
Gil Beyen
Vice Chairman |
|
Hilde Windels
Independent Director |
|
Jérôme Bailly
Chief Quality Officer & Deputy CEO |
|
Karine Charton
Chief Business Officer |
|
Leila Nicolas
Director |
|
Martine Ortin George
Independent Director |
|
Pascal Birman
Chief Medical Officer |
|
Philippe Archinard
Independent Director |
|
Robert Sebbag
Independent Director |
|
Thibaut du Fayet
Chief Executive Officer |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
